Showing 1-5 of 31 data studies & next generation registries:
Analyses and Insights from the OM1 Real-World Immunology Data Network

At OM1, we use both RWD  to create digital data networks and AI powered tools to answer research questions and  improve patient outcomes. In this E-Book, you will find insights, use cases, publications and more from the OM1 Immunology Data Network, including rheumatology, dermatology, gastroenterology, and respiratory conditions. Download>> *Due to proprietary information contained in[…]

New mammography guidance throws another twist into screening debate

Axios Tina Reed May 10, 2023 Read the full article>> New guidelines changing the recommended screening age for breast cancer to 40 years old from 50 are adding another wrinkle to the confusing discussion over when and how often to get mammograms. Driving the news: The draft guidance the U.S. Preventive Services Task Force released on Tuesday for[…]

Integrated Real-World Evidence Generation for Regulatory and Other Research

Wed, Apr 26, 2023 11:00 AM – 12:00 PM EDT Register >> Presenter: Rich Gliklich, CEO, OM1   Accessing and processing complex and disparate real-world data (RWD) for regulatory and non-regulatory research needs is costly for sponsors and burdensome for providers. Join this webinar to explore an automated, flexible platform approach to prospective research that[…]

1 2 3 7